全球首部2型糖尿病代谢手术治疗联合指南出台

2016-05-26 朱江帆 国际糖尿病

2016年5月24日,全球首部由多个国际上糖尿病组织参与制定的关于代谢手术治疗2型糖尿病的指南:“代谢手术作为2型糖尿病治疗方案:国际糖尿病组织联合声明”在线发表于美国糖尿病协会(ADA)官方杂志Diabetes Care。

2016年5月24日,全球首部由多个国际上糖尿病组织参与制定的关于代谢手术治疗2型糖尿病的指南:“代谢手术作为2型糖尿病治疗方案:国际糖尿病组织联合声明”在线发表于美国糖尿病协会(ADA)官方杂志Diabetes Care。这一指南得到45个国际组织官方支持和认可。国际顶级杂志Nature在同步发表的期刊上发表了相关评论。预期这部里程碑性指南的发表将对全球糖尿病治疗发生重大影响。
  
尽管越来越多的证据表明,减重/代谢手术能够治愈或显著改善2型糖尿病,但现有糖尿病的标准治疗方案并不包括手术选项。2015年9月,48位国际权威专家在英国伦敦联合召开第二届糖尿病外科治疗峰会(DSS-Ⅱ)期间,对经过三轮讨论所形成的共识初稿进行了临床证据回顾、解读、辩论和投票,最终达成共识,并通过了“代谢手术作为2型糖尿病治疗方案:国际糖尿病组织联合声明”。该指南是在回顾已有证据基础上,提出将药物和手术治疗相结合制定2型糖尿病最佳治疗方案的全球性建议。
  
国内反响
  
上海交通大学第六人民医院贾伟平教授:CDS非常高兴能够和国际上其他学术组织共同制定这部指南,推动糖尿病治疗的发展。针对伴有肥胖的糖尿病患者,传统治疗手段往往很难达到有效减重,从而纠正胰岛素抵抗、从病理生理水平阻断糖尿病发病;而减重手术则通过对胃肠道解剖序列重建,从多种途径减轻体重、恢复正常体脂分布、改善胰岛素抵抗及胰岛素分泌功能,使肥胖、糖尿病及其慢性并发症得到不同程度的逆转。另外,减重手术还可明显改善如高血压病、血脂紊乱、非酒精性脂肪肝、睡眠呼吸暂停综合征、骨关节疾病等肥胖相关合并症,大大提高患者的生存质量,产生良好的社会效益。
  
北京大学人民医院纪立农教授(本指南12名起草委员会成员之一,也是该委员会中唯一来自东亚地区的成员):在循证医学证据有限的情况下,既往仅个别学术组织和机构将代谢手术作为糖尿病治疗方案。随着国际上代谢手术治疗糖尿病临床证据的积累,特别是多个将代谢手术与当前标准药物治疗方案对照的随机分组研究的完成,使国际学术界逐渐对通过代谢手术治疗与肥胖相关的糖尿病有了更广泛的共识。本指南的发表代表着国际医学界已经正式接受代谢手术作为伴肥胖的2型糖尿病患者的标准治疗手段之一,是糖尿病治疗史上的重大里程碑。
  
ADA反响:全球糖尿病组织的共识——代谢手术被认为是2型糖尿病的标准治疗选择之一
  
Diabetes Care主编William T. Cefalu认为,考虑到该领域的迅速发展,关注哪些糖尿病患者可接受代谢手术治疗非常重要。这部新指南基于多项临床研究结果,证实了代谢手术对特定糖尿病患者是有效的,可显著改善预后。而且,这是迄今第一部推荐手术作为糖尿病治疗选择之一的指南。新指南推荐,Ⅲ级肥胖(BMI≥40 kg/m2)或虽予以生活方式和最佳药物治疗后血糖仍控制不佳的Ⅱ级肥胖(BMI 35.0-39.9 kg/m2)患者可考虑采用代谢手术治疗2型糖尿病。血糖控制不佳的Ⅰ级肥胖(BMI 30.0-34.9 kg/m2)的2型糖尿病患者也可考虑代谢手术治疗。另外,指南特别指出,亚裔2型糖尿病患者的BMI相对较低,因此,上述BMI阈值应相应减少2.5 kg/m2。
  
Francesco Rubino医生是我在美国纽约西奈山医院做fellow期间的同事。他现在是英国伦敦国王学院的一名代谢和减重外科教授,也是该指南起草委员会的主席。他指出,手术治疗完全背离了糖尿病的传统管理策略,这种改变基于临床所观察到的疗效以及肠道在代谢调节中的重要作用证据,使其成为干预糖尿病的合适靶点。
  
DUK反响:必须认可手术是2型糖尿病的一种治疗选择
  
包括英国糖尿病学会(DUK)在内的国际糖尿病组织组成的一个领导小组,呼吁认可减重手术作为2型糖尿病的标准治疗之一。DUK也呼吁将这部新指南完全并入到现有2型糖尿病治疗指南中,这样一来,任何达到手术治疗标准的患者就可接受治疗评估。
  
Nature评论:是从不同的角度来思考糖尿病的时候了
  
这部指南可能是近一个世纪以来2型糖尿病治疗领域发生的最根本性改变。这一指南基于多项临床研究,表明胃肠道手术比任何生活方式干预或药物治疗能更好地改善血糖水平,甚至长期缓解疾病。长期以来,大家认为糖尿病是不可逆转的。但证据表明,代谢手术可促使疾病缓解,这有助于激发更多探索糖尿病病因的研究开展,甚至重振大家寻找治愈糖尿病的希望。


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1804263, encodeId=46ba1804263f5, content=<a href='/topic/show?id=6f44e66723b' target=_blank style='color:#2F92EE;'>#糖尿病代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76672, encryptionId=6f44e66723b, topicName=糖尿病代谢)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Fri Sep 23 04:26:00 CST 2016, time=2016-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634661, encodeId=b63d163466131, content=<a href='/topic/show?id=5fa02543864' target=_blank style='color:#2F92EE;'>#代谢手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25438, encryptionId=5fa02543864, topicName=代谢手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4d422235205, createdName=贵阳, createdTime=Sun Dec 25 22:26:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88429, encodeId=2b59884297e, content=好想要封面那个图, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16d41732485, createdName=QQa6b025df, createdTime=Sat Jun 04 11:18:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88138, encodeId=4d0888138cc, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:39:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290585, encodeId=cc471290585ce, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat May 28 08:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1804263, encodeId=46ba1804263f5, content=<a href='/topic/show?id=6f44e66723b' target=_blank style='color:#2F92EE;'>#糖尿病代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76672, encryptionId=6f44e66723b, topicName=糖尿病代谢)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Fri Sep 23 04:26:00 CST 2016, time=2016-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634661, encodeId=b63d163466131, content=<a href='/topic/show?id=5fa02543864' target=_blank style='color:#2F92EE;'>#代谢手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25438, encryptionId=5fa02543864, topicName=代谢手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4d422235205, createdName=贵阳, createdTime=Sun Dec 25 22:26:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88429, encodeId=2b59884297e, content=好想要封面那个图, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16d41732485, createdName=QQa6b025df, createdTime=Sat Jun 04 11:18:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88138, encodeId=4d0888138cc, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:39:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290585, encodeId=cc471290585ce, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat May 28 08:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1804263, encodeId=46ba1804263f5, content=<a href='/topic/show?id=6f44e66723b' target=_blank style='color:#2F92EE;'>#糖尿病代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76672, encryptionId=6f44e66723b, topicName=糖尿病代谢)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Fri Sep 23 04:26:00 CST 2016, time=2016-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634661, encodeId=b63d163466131, content=<a href='/topic/show?id=5fa02543864' target=_blank style='color:#2F92EE;'>#代谢手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25438, encryptionId=5fa02543864, topicName=代谢手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4d422235205, createdName=贵阳, createdTime=Sun Dec 25 22:26:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88429, encodeId=2b59884297e, content=好想要封面那个图, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16d41732485, createdName=QQa6b025df, createdTime=Sat Jun 04 11:18:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88138, encodeId=4d0888138cc, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:39:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290585, encodeId=cc471290585ce, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat May 28 08:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
    2016-06-04 QQa6b025df

    好想要封面那个图

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1804263, encodeId=46ba1804263f5, content=<a href='/topic/show?id=6f44e66723b' target=_blank style='color:#2F92EE;'>#糖尿病代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76672, encryptionId=6f44e66723b, topicName=糖尿病代谢)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Fri Sep 23 04:26:00 CST 2016, time=2016-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634661, encodeId=b63d163466131, content=<a href='/topic/show?id=5fa02543864' target=_blank style='color:#2F92EE;'>#代谢手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25438, encryptionId=5fa02543864, topicName=代谢手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4d422235205, createdName=贵阳, createdTime=Sun Dec 25 22:26:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88429, encodeId=2b59884297e, content=好想要封面那个图, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16d41732485, createdName=QQa6b025df, createdTime=Sat Jun 04 11:18:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88138, encodeId=4d0888138cc, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:39:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290585, encodeId=cc471290585ce, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat May 28 08:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]
    2016-06-02 沉心多思

    好文章,得多学习了!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1804263, encodeId=46ba1804263f5, content=<a href='/topic/show?id=6f44e66723b' target=_blank style='color:#2F92EE;'>#糖尿病代谢#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76672, encryptionId=6f44e66723b, topicName=糖尿病代谢)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/iaP1mV9qBwx5tE2F4xcG1r4x1PibWvluIFLB8VsViakqNMBia2Z0wFibVrYwDEILvHB1OomzzTAAGy5MVl5BrdEv9Bw/132, createdBy=e11f100, createdName=guguangxiang, createdTime=Fri Sep 23 04:26:00 CST 2016, time=2016-09-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1634661, encodeId=b63d163466131, content=<a href='/topic/show?id=5fa02543864' target=_blank style='color:#2F92EE;'>#代谢手术#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25438, encryptionId=5fa02543864, topicName=代谢手术)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4d422235205, createdName=贵阳, createdTime=Sun Dec 25 22:26:00 CST 2016, time=2016-12-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88429, encodeId=2b59884297e, content=好想要封面那个图, beContent=null, objectType=article, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=16d41732485, createdName=QQa6b025df, createdTime=Sat Jun 04 11:18:00 CST 2016, time=2016-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=88138, encodeId=4d0888138cc, content=好文章,得多学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=53751677671, createdName=沉心多思, createdTime=Thu Jun 02 02:39:00 CST 2016, time=2016-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1290585, encodeId=cc471290585ce, content=<a href='/topic/show?id=e86454454ea' target=_blank style='color:#2F92EE;'>#手术治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54454, encryptionId=e86454454ea, topicName=手术治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=920c231, createdName=lixiaol, createdTime=Sat May 28 08:26:00 CST 2016, time=2016-05-28, status=1, ipAttribution=)]

相关资讯

Obesity:代谢手术后即使女性体重稳定不变,内脏和肌间脂肪组织也持续减少

研究证明,代谢手术可以显著的降低体重,而且脂肪组织总量的降低占总体重减少量的80%,而且,身体不同部位的脂肪组织沉积会导致与肥胖相关的各种不同的并发症,如胰岛素抵抗和心血管疾病。目前,代谢手术对脂肪组织沉积的影响仍不清楚。大多数的研究使用单一的腹部切片来评估内脏脂肪组织和皮下脂肪组织的贮存情况。最近,来自纽约的Tatiana Toro-Ramos和他的团队,使用全身的MRI,来评估代谢手术前和代谢

NEJM:代谢手术后,体重下降能否给生活方式、糖尿病、心血管危险因素方面带来持久获益呢?

体重下降可以在短期内防治和改善,代谢和心血管疾病风险;但是,体重下降带来的这些受益能否随着年龄的增长一直保持下去呢?最近,发表新英格兰杂志上的一篇文章,很好的回答这一问题。Lars博士和他的团队,在瑞典肥胖研究中心进行了一项前瞻性的受控试验,分为减肥手术组和常规的肥胖治疗组。所有登记注册的受试者中,2年的随访数据显示:4047位随访者(平均年龄48岁,平均BMI41),10年的随访数据显示:170

什么是代谢手术?

在20世纪后半叶,研究人员想通过外科手术(如肠旁路术)来治疗高脂血症和高胆固醇等一系列代谢性疾病。1995年,Walter博士和他的研究小组发表了一篇名为“谁能想到?手术竟是治疗成人起病的糖尿病最有效的手段”。自从那一篇具有里程碑意义的论文发表后,逐渐出现很多证据表明,手术可以治愈/改善一些代谢性疾病,特别是成人起病的糖尿病或2型糖尿病。2009年,美国减肥手术协会(ASB)更名为美国代谢和减肥手

Diabetes Care:减重/代谢手术治疗BMI低于35的2型糖尿病患者

减重手术在过去25年主要被用于BMI≥35kg/m2的患者。然而目前有较强证据表明减重手术可以明显改善或导致2型糖尿病缓解,部分机制是与体重无关的,并且基线水平的BMI不能预测手术带来的血糖或心血管方面的获益。这促使人们考虑将这一“代谢手术”应用到2型糖尿病的治疗上,包括那些BMI<35kg/m2的患者,他们是糖尿病患者的主要组成部分。一个涵盖了11个随机临床试验(RCT)的meta分析比较